Resistance to recombinant human erythropoietin therapy in haemodialysis patients

To better clarify the mechanism of resistance to recombinan thuman erythropoietin (rhEPO) therapy in haemodialysis patients, we studied systemic changes associated with resistance to rhEPO therapy in haemodialysis patients under rhEPO therapies, with particular interest on inflammation, leukocyte ac...

Full description

Bibliographic Details
Main Author: Costa, Elísio (author)
Other Authors: Lima, Margarida (author), Rocha, Susana (author), Pereira, Petronila Rocha (author), Reis, Flávio (author), Castro, Elisabeth (author), Teixeira, Frederico (author), Miranda, Vasco (author), Faria, Maria do Sarmento (author), Loureiro, Alfredo (author), Quintanilha, Alexandre (author), Belo, Luís (author), Santos-Silva, Alice (author)
Format: article
Language:eng
Published: 2013
Subjects:
Resistance to recombinant human erythropoietin
Haemodialysis
Erythropoietin
Inflammation
Iron status
Leukocyte activation
Eritropoietina humana recombinante
hemodiálise
inflamação
ciclo do ferro
activação leucocitária
Online Access:http://hdl.handle.net/10400.14/9882
Country:Portugal
Oai:oai:repositorio.ucp.pt:10400.14/9882

Internet

http://hdl.handle.net/10400.14/9882

Similar Items